Showing results (161-170 of 190) with videos related to

Sort By:
Pageof 19
Experimental Hematology|December 18, 2021
Transcriptional differences between JAK2-V617F and wild-type bone marrow cells in patients with myeloproliferative neoplasmsDebra Van Egeren, Baransel Kamaz, Shichen Liu, et al.
The Journal of Infectious Diseases|August 26, 2017
Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for MalignancyTimothy J Henrich, Kristen S Hobbs, Emily Hanhauser, et al.
Plos Pathogens|February 23, 2018
Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30Louise E Hogan, Joshua Vasquez, Kristen S Hobbs, et al.
American Journal of Hematology|November 10, 2017
A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemiaDaniel J DeAngelo, Andrew M Brunner, Lillian Werner, et al.
CBE Life Sciences Education|April 3, 2026
Equitable Group Work in Undergraduate Biology Courses: Leveraging a Complex Instruction Framework to Identify Pedagogical StrategiesMaria M De Jesus, Kristen S Hobbs, Paula E Adams, et al.
Blood|July 29, 2025
HiJAKing the Hematopoietic System: A Low-Frequency JAK2V617F Clone Drives Myeloproliferative Neoplasm PathologyDennis M Bonal, Alissa Oakes, Anna Chorzalska, et al.
Ejhaem|July 18, 2022
A nonrandomized phase I and biomarker trial of regorafenib in advanced myeloid malignanciesJoan How, Siyang Ren, Jennifer Lombardi-Story, et al.
Blood|March 19, 2025
Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCTZachariah DeFilipp, Haesook T Kim, Laura W Knight, et al.
Current Hematologic Malignancy Reports|July 11, 2025
Highlights from MPN Asia 2025: Advances in Molecular Pathogenesis and Therapeutic Strategies in Myeloproliferative NeoplasmsPrithviraj Bose, Zhijian Xiao, Hans C Hasselbalch, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Differences in expression of tumor suppressor, innate immune, inflammasome, and potassium/gap junction channel host genes significantly predict viral reservoir size during treated HIV infectionAshok K Dwivedi, David A Siegel, Cassandra Thanh, et al.
Pageof 19